Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's disease

REFERENCES

• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519-50; PMID:11283320; http://dx.doi.org/10.1146/annurev.neuro.24.1.519
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Haass C. Games played by rogue proteins in prion disorders and Alzheimer disease. Science 2003; 302:814-8; PMID:14593165; http://dx.doi.org/10.1126/science.1087348
   PubMed Web of Science ®Google Scholar
• Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 2009; 457:1128-32; PMID:19242475; http://dx.doi.org/10.1038/nature07761
   PubMed Web of Science ®Google Scholar
• Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435-9; PMID:15933194; http://dx.doi.org/10.1126/science.1110837
   PubMed Web of Science ®Google Scholar
• Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 2012; 15:1227-35; PMID:22820466; http://dx.doi.org/10.1038/nn.3178
   PubMed Web of Science ®Google Scholar
• Chiesa R. The elusive role of the prion protein and the mechanism of toxicity in prion disease. PLoS Pathog 2015; 11:e1004745; PMID:25951168; http://dx.doi.org/10.1371/journal.ppat.1004745
   PubMedGoogle Scholar
• Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 2004; 5:317-28; PMID:15034556; http://dx.doi.org/10.1038/nrn1368
   PubMed Web of Science ®Google Scholar
• Ochs K, Malaga-Trillo E. Common themes in PrP signaling: the Src remains the same. Front Cell Dev Biol 2014; 2:63; PMID:25364767; http://dx.doi.org/10.3389/fcell.2014.00063
   PubMed Web of Science ®Google Scholar
• Sempou E, Biasini E, Pinzón-Olejua A, Harris DA, Málaga-Trillo E. Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo. Mol Neurodegener 2016; 11:18; PMID:26860872; http://dx.doi.org/10.1186/s13024-016-0076-5
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289:1925-8; PMID:10988071; http://dx.doi.org/10.1126/science.289.5486.1925
   PubMed Web of Science ®Google Scholar
• Málaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, Stuermer CA. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol 2009; 7:e55
   PubMed Web of Science ®Google Scholar
• Montero JA, Heisenberg CP. Gastrulation dynamics: cells move into focus. Trends Cell Biol 2004; 14:620-7; PMID:15519851; http://dx.doi.org/10.1016/j.tcb.2004.09.008
   PubMed Web of Science ®Google Scholar
• Zhimin L, Tony H. Degradation of Activated Protein Kinases by Ubiquitination. Annu Rev Biochem 2009; 78:435-75; PMID:19489726; http://dx.doi.org/10.1146/annurev.biochem.013008.092711
   PubMed Web of Science ®Google Scholar
• Reinecke J, Caplan S. Endocytosis and the Src family of non-receptor tyrosine kinases. Biomolecular Concepts 2014; 5(2):143-55; PMID:25372749; http://dx.doi.org/10.1515/bmc-2014-0003
   PubMedGoogle Scholar
• McLachlan RW, Yap AS. Not so simple: the complexity of phosphotyrosine signaling at cadherin adhesive contacts. J Mol Med 2007; 85:545-54; PMID:17429596; http://dx.doi.org/10.1007/s00109-007-0198-x
   PubMed Web of Science ®Google Scholar
• Daniel JM, Reynolds AB. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 1997; 19:883-91; PMID:9363682; http://dx.doi.org/10.1002/bies.950191008
   PubMed Web of Science ®Google Scholar
• Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004; 303:1483-7; PMID:15001769; http://dx.doi.org/10.1126/science.1094291
   PubMed Web of Science ®Google Scholar
• Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HEM, Behrens J, Sommer T, Birchmeier W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002; 4:222-31; PMID:11836526; http://dx.doi.org/10.1038/ncb758
   PubMed Web of Science ®Google Scholar
• Ahn S, Kim J, Lucaveche CL, Reedy MC, Luttrell LM, Lefkowitz RJ, Daaka Y. Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor. J Biol Chem 2002; 277:26642-51; PMID:12011079; http://dx.doi.org/10.1074/jbc.M201499200
   PubMed Web of Science ®Google Scholar
• Wilde A, Beattie EC, Lem L, Riethof DA, Liu SH, Mobley WC, Soriano P, Brodsky FM. EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake. Cell 1999; 96:677-87; PMID:10089883; http://dx.doi.org/10.1016/S0092-8674(00)80578-4
   PubMed Web of Science ®Google Scholar
• Zimmerman B, Simaan M, Lee MH, Luttrell LM, Laporte SA. c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway. 2009; 21:103-10; PMID:18938240
   PubMedGoogle Scholar
• Yamada S, Nelson WJ. Synapses: sites of cell recognition, adhesion, and functional specification. Ann Rev Biochem 2007; 76:267-94; PMID:17506641; http://dx.doi.org/10.1146/annurev.biochem.75.103004.142811
   PubMed Web of Science ®Google Scholar
• Fiederling A, Ewert R, Andreyeva A, Jüngling K, Gottmann K. E-cadherin is required at GABAergic synapses in cultured cortical neurons. Neurosci Lett 2011; 501(3):167-72; http://dx.doi.org/10.1016/j.neulet.2011.07.009
   PubMed Web of Science ®Google Scholar
• Okamura K, Tanaka H, Yagita Y, Saeki Y, Taguchi A, Hiraoka Y, Zeng LH, Colman DR, Miki N. Cadherin activity is required for activity-induced spine remodeling. J Cell Biol 2004; 167:961-72; PMID:15569714; http://dx.doi.org/10.1083/jcb.200406030
   PubMed Web of Science ®Google Scholar
• Andreyeva A, Nieweg K, Horstmann K, Klapper S, Muller-Schiffmann A, Korth C, Gottmann K. C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-β. Brain 2012; 135:2140-54; PMID:22637581; http://dx.doi.org/10.1093/brain/aws120
   PubMed Web of Science ®Google Scholar
• Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesne SE. The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer disease. J Neurosci 2012; 32:16857-71a; PMID:23175838; http://dx.doi.org/10.1523/JNEUROSCI.1858-12.2012
   PubMed Web of Science ®Google Scholar
• Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997; 13:513-609; PMID:9442882; http://dx.doi.org/10.1146/annurev.cellbio.13.1.513
   PubMed Web of Science ®Google Scholar
• Lau L, Huganir RL. Role of Tyrosine Phosphorylation in the Nervous System. In: Siegel GJ, Agranoff BW, Alberz RW, Fischer SK, Uhler MD, eds. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Philadelphia: Lippincott-Raven, 1999
   Google Scholar
• Buckley KM, Melikian HE, Provoda CJ, Waring MT. Regulation of neuronal function by protein trafficking: a role for the endosomal pathway. J Physiol 2000; 525(Pt 1):11-9; PMID:10811720; http://dx.doi.org/10.1111/j.1469-7793.2000.t01-2-00011.x
   PubMed Web of Science ®Google Scholar
• Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer disease. Hum Mol Genetics 2010; 19:R12-20; PMID:20413653; http://dx.doi.org/10.1093/hmg/ddq160
   PubMed Web of Science ®Google Scholar
• Lombardo S, Maskos U. Role of the nicotinic acetylcholine receptor in Alzheimer disease pathology and treatment. Neuropharmacol: Elsevier Ltd 2015; 96:255-62
   PubMed Web of Science ®Google Scholar
• Wang K, Hackett JT, Cox ME, Van Hoek M, Lindstrom JM, Parsons SJ. Regulation of the neuronal nicotinic acetylcholine receptor by SRC family tyrosine kinases. J Biol Chem 2004; 279(10):8779-86; http://dx.doi.org/10.1074/jbc.M309652200
   PubMed Web of Science ®Google Scholar
• Mohamed AS, Swope SL. Phosphorylation and cytoskeletal anchoring of the acetylcholine receptor by Src class protein-tyrosine kinases. Activation by rapsyn. J Biol Chem 1999; 279(10):20529-39; http://dx.doi.org/10.1074/jbc.274.29.20529
   Web of Science ®Google Scholar
• Kumari S, Borroni V, Chaudhry A, Chanda B, Massol R, Mayor S, Barrantes FJ. Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway. J Cell Biol 2008; 181(7):1179-93; PMID:18591431; http://dx.doi.org/10.1083/jcb.200709086
   PubMed Web of Science ®Google Scholar
• Rudell JC, Borges LS, Rudell JB, Beck KA, Ferns MJ. Determinants in the β and delta subunit cytoplasmic loop regulate Golgi trafficking and surface expression of the muscle acetylcholine receptor. J Biol Chem 2014; 289:203-14; PMID:24240098; http://dx.doi.org/10.1074/jbc.M113.502328
   PubMed Web of Science ®Google Scholar
• Rissman RA, De Blas AL, Armstrong DM. GABA Areceptors in aging and Alzheimer disease. J Neurochem 2007; 103(4):1285-92; PMID:17714455; http://dx.doi.org/10.1111/j.1471-4159.2007.04832.x
   PubMed Web of Science ®Google Scholar
• Li Y, Sun H, Chen Z, Xu H, Bu G, Zheng H. Implications of GABAergic Neurotransmission in Alzheimer Disease. Front Aging Neurosci 2016; 8:31:11; PMID:26941642
   PubMed Web of Science ®Google Scholar
• Limon A, Reyes-Ruiz JM, Miledi R. Loss of functional GABA(A) receptors in the Alzheimer diseased brain. Proc Natl Acad Sci USA 2012; 109(25):10071-6; PMID:22691495; http://dx.doi.org/10.1073/pnas.1204606109
   PubMed Web of Science ®Google Scholar
• Tretter V, Revilla-Sanchez R, Houston C, Terunuma M, Havekes R, Florian C, Jurd R, Vithlani M, Michels G, Couve A, et al. Deficits in spatial memory correlate with modified {gamma}-aminobutyric acid type A receptor tyrosine phosphorylation in the hippocampus. Proc Natl Acad Sci U S A 2009; 106:20039-44; PMID:19903874; http://dx.doi.org/10.1073/pnas.0908840106
   PubMed Web of Science ®Google Scholar
• Kittler JT, Chen G, Kukhtina V, Vahedi-Faridi A, Gu Z, Tretter V, Smith KR, McAinsh K, Arancibia-Carcamo IL, Saenger W, et al. Regulation of synaptic inhibition by phospho-dependent binding of the AP2 complex to a YECL motif in the GABAA receptor gamma2 subunit. Proc Natl Acad Sci U S A 2008; 105:3616-21; PMID:18305175; http://dx.doi.org/10.1073/pnas.0707920105
   PubMed Web of Science ®Google Scholar
• Jurd R, Tretter V, Walker J, Brandon NJ, Moss SJ. Fyn kinase contributes to tyrosine phosphorylation of the GABAA receptor γ2 subunit. Mol Cell Neurosci: Elsevier Inc. 2010; 44(2):129-34; http://dx.doi.org/10.1016/j.mcn.2010.03.002
   PubMed Web of Science ®Google Scholar
• Carleton A, Tremblay P, Vincent JD, Lledo PM. Dose-dependent, prion protein (PrP)-mediated facilitation of excitatory synaptic transmission in the mouse hippocampus. Pflugers Arch 2001; 442:223-9; PMID:11417218; http://dx.doi.org/10.1007/s004240100523
   PubMed Web of Science ®Google Scholar
• Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-7; PMID:8035877; http://dx.doi.org/10.1038/370295a0
   PubMed Web of Science ®Google Scholar
• Le Pichon CE, Valley MT, Polymenidou M, Chesler AT, Sagdullaev BT, Aguzzi A, Firestein S. Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nat Neurosci 2009; 12:60-9; PMID:19098904; http://dx.doi.org/10.1038/nn.2238
   PubMed Web of Science ®Google Scholar
• Ferrer I, Puig B. GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease. Acta Neuropathol 2003; 106:311-8; PMID:12835949; http://dx.doi.org/10.1007/s00401-003-0732-z
   PubMed Web of Science ®Google Scholar
• Guentchev M, Groschup MH, Kordek R, Liberski PP, Budka H. Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol 1998; 8:615-23; PMID:9804371; http://dx.doi.org/10.1111/j.1750-3639.1998.tb00188.x
   PubMed Web of Science ®Google Scholar
• Askanas V, Bilak M, Engel WK, Leclerc A, Tome F. Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions. Neurosci Lett 1993; 159:111-4; PMID:8264949; http://dx.doi.org/10.1016/0304-3940(93)90811-X
   PubMed Web of Science ®Google Scholar
• Re L, Rossini F, Re F, Bordicchia M, Mercanti A, Fernandez OS, Barocci S. Prion protein potentiates acetylcholine release at the neuromuscular junction. Pharmacological Res 2006; 53:62-8; PMID:16256362; http://dx.doi.org/10.1016/j.phrs.2005.09.002
   PubMed Web of Science ®Google Scholar
• Beraldo FH, Arantes CP, Santos TG, Queiroz NG, Young K, Rylett RJ, Markus RP, Prado MA, Martins VR. Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem 2010; 285:36542-50; PMID:20837487; http://dx.doi.org/10.1074/jbc.M110.157263
   PubMed Web of Science ®Google Scholar
• Petrakis S, Irinopoulou T, Panagiotidis CH, Engelstein R, Lindstrom J, Orr-Urtreger A, Gabizon R, Grigoriadis N, Sklaviadis T. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract. Eur J Neurosci 2008; 27:612-20; PMID:18279314; http://dx.doi.org/10.1111/j.1460-9568.2008.06037.x
   PubMed Web of Science ®Google Scholar
• Miller MB, Geoghegan JC, Supattapone S. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism. PLoS Pathog 2011; 7(7):e1002128; PMID:21779169; http://dx.doi.org/10.1371/journal.ppat.1002128
   PubMedGoogle Scholar
• Risse E, Nicoll AJ, Taylor WA, Wright D, Badoni M, Yang X, Farrow MA, Collinge J. Identification of a compound that disrupts binding of Amyloid-β to the prion protein using a novel fluorescence-based assay. J Biol Chem 2015; 290(27):17020-8; PMID:25995455; http://dx.doi.org/10.1074/jbc.M115.637124
   PubMed Web of Science ®Google Scholar
• Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, Asante EA, Farrow MA, Sessions RB, Saibil HR, et al. Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun 2011; 2:336; PMID:21654636; http://dx.doi.org/10.1038/ncomms1341
   PubMed Web of Science ®Google Scholar
• Kam TI, Gwon Y, Jung YK. Amyloid β receptors responsible for neurotoxicity and cellular defects in Alzheimer disease. Cell Mol Life Sci 2014; 71(24):4803-13; PMID:25151011; http://dx.doi.org/10.1007/s00018-014-1706-0
   PubMed Web of Science ®Google Scholar
• Kaufman AC, Salazar SV, Haas LT, Yang J, Kostylev MA, Jeng AT, Robinson SA, Gunther EC, van Dyck CH, Nygaard HB, et al. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann Neurol 2015; 77:953-71; PMID:25707991; http://dx.doi.org/10.1002/ana.24394
   PubMed Web of Science ®Google Scholar
• Nygaard HB, van Dyck CH, Strittmatter SM. Fyn kinase inhibition as a novel therapy for Alzheimer disease. Alzheimer Res Ther 2014; 6:8; PMID:24495408; http://dx.doi.org/10.1186/alzrt238
   PubMed Web of Science ®Google Scholar
• Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA, Kaufman AC, Rosenberg BJ, Sekine-Konno T, Varma P, et al. A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer disease. Alzheimer Res Ther 2015; 7:35; PMID:25874001; http://dx.doi.org/10.1186/s13195-015-0119-0
   PubMed Web of Science ®Google Scholar